Song X, Zhang W, Zhang Y, Zhang H, Fu Z, Ye J,
Liu L, Song X, Wu Y. Expression of semaphorin 3A and neuropilin 1
with clinicopathological features and survival in
human tongue cancer. Med Oral Patol Oral Cir Bucal. 2012
Nov 1;17 (6):e962-68.
doi:10.4317/medoral.18168
http://dx.doi.org/doi:10.4317/medoral.18168
|
1. Forastiere AA, Ang
K, Brizel D, Brockstein
BE, Dunphy F, Eisele DW,
et al. Head and neck cancers. J Natl Compr Canc Netw.
2005;3:316-91. |
||||
|
|
||||
|
2. Casiglia J, Woo SB. A comprehensive
review of oral cancer. Gen Dent. 2001;49:72-82. |
||||
|
|
||||
|
3. Hunter KD, Parkinson EK, Harrison PR. Profiling early head and neck
cancer. Nat Rev Cancer.
2005;5:127-35. |
||||
|
|
||||
|
4. Vokes EE, Weichselbaum
RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med. 1993;328:184-94. |
||||
|
|
||||
|
5. Morris LG, Veeriah S, Chan TA. Genetic
determinants at the interface of cancer and neurodegenerative disease. Oncogene. 2010;24,3453-64. |
||||
|
|
||||
|
6. Cao L, Liu X, Lin EJ, Wang C, Choi EY, Riban V, et al. Environmental and Genetic Activation of a
Brain-Adipocyte BDNF/Leptin
Axis Causes Cancer Remission and Inhibition. Cell.
2010;142:52-64. |
||||
|
|
||||
|
7. Chilton JK. Molecular mechanisms of axon guidance. Dev Biol. 2006;92:13-24. |
||||
|
|
||||
|
8. Dickson BJ. Molecular mechanisms of axon guidance. Science. 2002;298:1959-64. |
||||
|
|
||||
|
9. Jia H, Cheng L, Tickner
M, Bagherzadeh A, Selwood
D, Zachary I. Neuropilin-1 antagonism in human carcinoma cells inhibits
migration and enhances chemosensitivity. Br J Cancer. 2010;102:541-52. |
||||
|
|
||||
|
10. Bielenberg DR, Hida
Y, Shimizu A, Kaipainen A, Kreuter
M, Kim CC, et al. Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic
tumor phenotype. J Clin
Invest. 2004,114:1260-71. |
||||
|
|
||||
|
11. Christensen C, Ambartsumian N, Gilestro G, Thomsen B, Comoglio
P, Tamagnone L, et al. Proteolytic
processing converts the repelling signal Sema3E into an inducer of invasive
growth and lung metastasis. Cancer Res. 2005;65:6167-77. |
||||
|
|
||||
|
12. Osada H, Tokunaga T, Nishi M, Hatanaka H, Abe Y, Tsugu A, et
al. Overexpression of the neuropilin1 gene
correlated with poor prognosis in homan glioma. Anticancer Res. 2004;24:547-52. |
||||
|
|
||||
|
13. Guttmann-Raviv N, Kessler O, Shraga-Heled N, Lange T, Herzog Y, Neufeld G. The neuropilins and their role in tumorigensis
and tumor progression. Cancer Lett. 2006;8:1-11. |
||||
|
|
||||
|
14. Rolny
C, Capparuccia L, Casazza
A, Mazzone M, Vallario A,
Cignetti A, et al. The tumor suppressor semaphorin 3B triggers a prometastatic
program mediated by interleukin 8 and the tumor microenvironment. J Exp Med.
2008;205:1155-71. |
||||
|
|
||||
|
15. Zheng C, Zhou Q, Wu F, Peng Q, Tang A, Liang H, et al. Semaphorin3F
down-regulates the expression of integrin
alpha(v)beta3 and sensitizes multicellular tumor
spheroids to chemotherapy via the neuropilin-2 receptor in vitro. Chemotherapy. 2009;55:344-52. |
||||
|
|
||||
|
16. Basile JR, Castilho RM, Williams VP, Gutkind JS. Semaphorin 4D
provides a link between axon guidance processes and tumor–induced
angiogenesis. Proc Natl Acad
Sci U S A. 2006;103:9017-22. |
||||
|
|
||||
|
17. Yacoub M, Coulon
A, Celhay O, Irani J, Cussenot O, Fromont G.
Differential expression of the semaphorin 3A
pathway in prostatic cancer. Histopathology. 2009;55:392-8. |
||||
|
|
||||
|
18. Guttmann-Raviv N, Shraga-Heled
N, Varshavsky A, Guimaraes-Sternberg
C, Kessler O, Neufeld G. Semaphorin-3A and semaphoring-3F work together to
repel endothelial cells and to inhibit their survival by induction of
apoptosis. J Biol Chem. 2007;282:26294-305. |
||||
|
|
||||
|
19. Engels K, Knauer SK, Metzler D, Simf C, Struschka O, Bier C, et al. Dynamic intracellular survivin
in oral squamous cell carcinoma: underlying
molecular mechanism and potential as an early prognostic marker. J Pathol. 2007;211:532-40. |
||||
|
|
||||
|
20. Neufeld G, Shraga-Heled N, Lange T,
Guttmann-Raviv N, Herzog Y, Kessler O. Semaphorins in cancer. Front Biosci. 2005;10:751-60. |
||||
|
|
||||
|
21. Goshima Y, Ito T, Sasaki Y, Nakamura F. Semaphorins as signals for cellrepulsion
and invasion. J Clin
Invest. 2002;109:993-8. |
||||
|
|
||||
|
22. Pan H, Wanami LS, Dissanayake
TR, Bachelder RE. Autocrine
semaphorin3A stimulates alpha2 beta1 integrin
expression/function in breast tumor cells. Breast Cancer Res Treat. 2009;118:197-205. |
||||
|
|
||||
|
23. Herman JG, Meadows GG. Increased class 3 semaphorin
expression modulates the invasive and adhesive properties of prostate cancer
cells. Int J Oncol. 2007;30:1231-8. |
||||
|
|
||||
|
24. Catalano
A, Caprari P, Rodilossi
S, Betta P, Castellucci
M, Casazza A, et al. Cross-talk between vascular
endothelial growth factor and semaphorin-3A pathway in the regulation of
normal and malignant mesothelial cell
proliferation. FASEB J. 2004;18:358-60. |
||||
|
|
||||
|
25. Oinuma I, Ishikawa Y, Katoh H, Negishi M. The semaphorin 4D receptor plexin-B1 is a GTPase
activating protein for R-Ras. Science. 2004;305:862-5. |
||||
|
|
||||
|
26. Toyofuku
T, Yoshida J, Sugimoto T,
Zhang H, Kumanogoh A, Hori
M, et al. FARP2 triggers signals for Sema3A-mediated axonal repulsion. Nat Neurosci. 2005;8:1712-9. |
||||
|
|
||||
|
27. Gaziel-Sovran A, Segura MF, Di Micco R, Collins MK, Hanniford
D, Vega-Saenz de Miera E, et al. miR-30b/30d
regulation of GalNAc transferases
enhances invasion and immunosuppression during
metastasis. Cancer Cell. 2011;20:104-18. |
||||
|
|
||||
|
28. Miao HQ, Soker S, Feiner
L, Alonso JL, Raper JA, Klagsbrun
M. Neuropilin-1 mediates collapsin-1/semaphorin III
inhibition of endothelial cell motility: functional competition of
collapsin-1 and vascular endothelial growth factor-165. J Cell Biol.
1999;146:233-42. |
||||
|
|
||||
|
29. Bielenberg DR, Pettaway
CA, Takashima S, Klagsbrun M. Neuropilins
in neoplasms: expression, regulation, and function.
Exp Cell Res. 2006;312:584-93. |
||||
|
|
||||
|
30. Latil A, Bièche
I, Pesche S, Valéri A,
Fournier G, Cussenot O, et al. VEGF overexpression in clinically localized prostate tumors
and neuropilin-1 overexpression in metastatic
forms. Int J Cancer. 2000;89:167-71. |
||||
|
|
||||
|
31. Hansel DE, Wilentz RE, Yeo CJ, Schulick RD, Montgomery
E, Maitra A. Expression of
neuropilin-1 in high-grade dysplasia, invasive cancer, and metastases of the
human gastrointestinal tract. Am J Surg Pathol. 2004;28:347-56. |
||||
|
|
||||
|
32. Ochiumi T, Kitadai
Y, Tanaka S, Akagi M, Yoshihara M, Chayama K. Neuropilin-1 is involved in regulation of
apoptosis and migration of human colon cancer. Int J Oncol. 2006;29:105-16. |
||||
|
|
||||
|
33. Bagnard D, Vaillant
C, Khuth ST, Dufay N, Lohrum
M, Puschel AW, et al. Semaphorin
3A-vascular endothelial growth factor-165 balance mediates migration and
apoptosis of neural progenitor cells by the recruitment of shared receptor. J Neurosci. 2001;21:3332-41. |
||||
|
|
||||
|
34. Narazaki M, Tosato
G. Ligand-induced internalization selects use of
common receptor neuropilin-1 by VEGF165 and semaphorin3A. Blood. 2006;107:3892-3901. |
||||
|
|
||||